A University of Pittsburgh child psychiatrist who conducted company-sponsored clinical trials on adolescent use of the antidepressant Paxil also conferred with the company on how to respond to press inquiries challenging the safety of the drug for adolescents, reports the BBC investigative program, Panorama. The psychiatrist, Dr. Neal Ryan, sent emails to GlaxoSmithKline dating to 2002 requesting media advice.